loading

Fulcrum Therapeutics Inc Stock (FULC) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
100.00%
-
0.871 0.759 0.88 0.295
Operating Expenses
3.36%
29.83
28.86 28.20 28.17 28.23
Operating Income/Loss
6.58%
-29.83
-27.99 -27.44 -27.29 -27.94
Income/Loss From Continuing Operations Before Tax
8.54%
-26.87
-24.76 0.759 -23.78 -24.78
Income/Loss From Continuing Operations After Tax
8.54%
-26.87
-24.76 -24.02 -23.78 -24.78
Net Income/Loss
8.54%
-26.87
-24.76 -24.02 -23.78 -24.78
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
32,696%
0.062
0.000189 0.0618 0.0618 0.0597
Diluted Average Shares
32,696%
0.062
0.000189 0.0618 0.0618 0.0597
Basic Earnings Per Share
7.50%
-0.43
-0.40 -0.39 -0.38 -0.41
Diluted Earnings Per Share
7.50%
-0.43
-0.40 -0.39 -0.38 -0.41
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):